|
|
Line 8: |
Line 8: |
| ===Usage and Biology=== | | ===Usage and Biology=== |
| | | |
− | <!-- -->
| |
| | | |
− | <html lang="en">
| |
− |
| |
− | <head>
| |
− | <meta charset="UTF-8">
| |
− | <meta http-equiv="X-UA-Compatible" content="IE=edge">
| |
− | <meta name="viewport" content="width=device-width, initial-scale=1.0">
| |
− | <title>Document</title>
| |
− | </head>
| |
− |
| |
− | <body>
| |
− | <p style="font-size: 180%; font-weight: bold;">Build:
| |
− | </p>
| |
− |
| |
− |
| |
− | </div>
| |
− | <p style="font-size: 160%; font-weight: bold;">1.Experimental Methods
| |
− | <p>1.1 Construction of PCWJ-YciA-sfp-MmCAR-YahK<br>
| |
− | The pCWJ plasmid was extracted from a laboratory conserved strain. In-Fusion cloning was used to ligate the above vector to the Ptrc-YciA-sfp-MmCAR-YahK fragment.
| |
− | <br>1.2 Construction of PRSFDuet-YciA-sfp-MmCAR-YahK<br>
| |
− | The PRSFDuet plasmid was extracted from laboratory conserved strains. The fragment Ptrc-YciA-sfp-MmCAR-sfp-Yahk was amplified by PCR using PCWJ-YciA-sfp-MmCAR-YahK as a template, and Ptrc-YciA-MmCAR-sfp-Yahk was ligated by In-fusion cloning to the vector PRSFDuet that was linearized using PCR for homologous recombination ligation.
| |
− | </p >
| |
− |
| |
− | <p style="font-size: 160%; font-weight: bold;">Result
| |
− |
| |
− | </div>
| |
− |
| |
− | <p>By comparing the fermentation production of 1,5-PDO content with the previous KA30 with PCWJ+PTRC99a, we can clearly see that KA30 with PRSFDuet+PTRC99a produced more 1,5-PDO, therefore, we decided to use both vectors, PRSFDuet and PTRC99a, in all our future experiments. </p >
| |
− |
| |
− | </body>
| |
| | | |
| </html> | | </html> |
Revision as of 21:57, 11 October 2023
Ptrc-sfp-MmCAR-YahK
(1)Ptrc is a promoter.(2)YahK is a acyl-CoA thioester hydrolase from Haemophilus influenzae.(3) Sfp is a phosphopantetheinyl transferase from Bacilus subtilis.(4) MmCAR is a Carboxylic acid reductase from Mycobacterium marinum.(5) YahK is a NADPH-dependent aldehyde reductase.